The Indian endocrinologist faced Prof. Bill Herman of the University of Michigan at a Cambridge diabetes seminar, with the audience joining in.
Recap by typeshit. Post by @DrAmbrishMithal on X.
A retrospective study in Cureus looks back at how well once-weekly semaglutide worked, and how safe it was, for teenagers with obesity.
Presented at Sleep Europe 2026, both trials found retatrutide lowered the apnea-hypopnea index more than placebo, including in people with type 2 diabetes.
Endpoints News
Endpoints reports Eli Lilly is building a case for its triple agonist beyond obesity, where a launch is expected next year, with sleep apnea next in line.
Observational data link GLP-1 drugs to fewer cases of some cancers, but trials have yet to show they prevent cancer or help survival after a diagnosis.
At the Cambridge diabetes seminar in Kochi, Mithal faced Prof Bill Herman of the University of Michigan, with the audience joining in.
At a Cambridge diabetes seminar in Kochi, Mithal and the University of Michigan professor argued the motion that GLP-1 drugs are a cure for obesity, with the audience joining in.
Loading…